Anthem Biosciences Limited (BOM:544449)
738.45
+14.75 (2.04%)
At close: Apr 21, 2026
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 414.36 billion as of April 22, 2026.
Market Cap
414.36B
Enterprise Value
405.14B
Revenue
20.02B
Ranking
n/a
PE Ratio
85.49
Stock Price
738.45
Market Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has increased from 410.17B to 414.36B, an increase of 1.02%. That is a compound annual growth rate of 1.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 414.36B | 13.25% |
| Dec 31, 2025 | 365.89B | -10.80% |
| Jul 21, 2025 | 410.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KEI Industries | 466.32B |
| Mphasis | 460.95B |
| PI Industries | 460.72B |
| J.K. Cement | 442.14B |
| Balkrishna Industries | 441.64B |
| NLC India | 422.02B |
| GlaxoSmithKline Pharmaceuticals | 412.01B |
| Authum Investment & Infrastructure | 396.89B |